Targeted prostate biopsy: opportunities and challenges in the era of multiparametric prostate magnetic resonance imaging.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. 3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy.Academic radiology · 2017
   Article
2. [Prostate biopsy: Procedure in the clinical routine].Der Urologe. Ausg. A · 2015
   Review
3. Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer.The Kaohsiung journal of medical sciences · 2015
   Review
4. Assessment of change in prostate volume and shape following surgical resection through co-registration of in-vivo MRI and fresh specimen ex-vivo MRI.Clinical radiology · 2014
   Article

Corrections and comments

• Comment on
  Correlation of magnetic resonance imaging tumor volume with histopathology.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as